Dr. Thomas Hartung, Director of the Center for Alternatives to Animal Testing (CAAT) at the Johns Hopkins Bloomberg School of Public Health, has endorsed the public launch of ToxIndex, an agentic AI platform developed by Insilica Inc. that produces comprehensive, source-traceable toxicological risk assessments in just a few hours.

A new computational tool infers changes occurring at the ends of the chromosomes housing our DNA. It does so by detecting structural alterations in cells and tissues captured in images taken of routine medical biopsies, according to findings published March 16, 2026, in Cell Reports Methods.

In testing the new tool called TLPath, the scientists were able to more accurately predict telomere length from the imaged biopsies than if they based their prediction solely on the age of patients when they donated their samples. The scientists further evaluated the model’s prediction capabilities by demonstrating that it could identify telomere length differences between individuals of the exact same chronological age.

Anglia Ruskin University (ARU) and Cambridge-based global semiconductor and software design leader Arm have officially opened the ARU Arm AI Lab in Cambridge, England.

Biobots are fascinating tiny self-powered living robots built exclusively using frog embryonic cells. Developed in the laboratories of Wyss Institute Associate Faculty member and Tufts University Professor Michael Levin and his collaborators, they are remarkably motile, moving autonomously through aqueous environments, and exhibit other exciting properties, including the ability to self-replicate and respond to sound stimuli. 

Now, Levin’s team endowed biobots with a nervous system by creating the first “neurobots.” Their new study shows that novel types of nervous systems self-organize within neurobots, with neuronal processes extending in between neurons as well as towards non-neuronal cells lining the surface of the bots. The study is published in Advanced Science.